<unk>  refers to a regimen consisting of mesna, ifosfamide, mitoxantrone, etoposide, and rituximab used to treat relapsed or refractory Hodgkin's lymphoma and non-Hodgkin's lymphoma.
MINE-R regimen
ICE-R regimen
TIP regimen
FMC-R regimen
DCEP regimen
RCD regimen
R-MINE regimen
DHAX-R regimen